Bright Minds Biosciences is focused on developing psychedelics-based drugs to treat various central nervous systems and mental health disorders. The company says it currently has a pipeline of patented serotonin 2A and 2C agonists, or substances that initiate a biological response when combined with a receptor.

Name Bright Minds Biosciences
Symbol DRUG